Management of Ventricular Tachycardia Storm
Intravenous amiodarone and beta blockers are the cornerstone treatments for patients experiencing ventricular tachycardia storm, with immediate electrical cardioversion indicated for hemodynamically unstable patients. 1, 2
Initial Assessment and Stabilization
Hemodynamic status assessment:
- If unstable (hypotension, angina, pulmonary edema): Immediate synchronized cardioversion starting at 100J for monomorphic VT or 200J unsynchronized shock for polymorphic VT 1
- If stable: Proceed with pharmacological management
Correct underlying causes:
Pharmacological Management
First-line Therapy:
Amiodarone:
Beta blockers:
Alternative/Second-line Options:
Procainamide:
Lidocaine:
For Specific Types of VT:
For Torsades de Pointes:
- Magnesium sulfate: 8 mmol bolus followed by infusion 1, 2
- Correct bradycardia with temporary pacing 1
- Isoproterenol for pause-dependent torsades (if no congenital LQTS) 1
- Potassium repletion to 4.5-5 mmol/L 1, 2
For Polymorphic VT:
- IV beta blockers are the single most effective therapy 1, 2
- Consider revascularization if ischemia-related 1
Non-pharmacological Interventions
Overdrive pacing:
General anesthesia:
- May be considered for refractory cases 1
Catheter ablation:
Coronary revascularization:
- Indicated when VT is due to acute myocardial ischemia 1
Long-term Management
- Transition to oral amiodarone (effective in 69-75% of patients with refractory VT) 2, 5
- Consider ICD implantation for secondary prevention 1
- Long-term oral amiodarone dosing: Initial loading 800 mg/day for 6 weeks, then maintenance 600 mg/day 5
- Monitor for amiodarone toxicity (occurs in approximately 50% of patients on long-term therapy) 5
Monitoring During Treatment
- Continuous cardiac monitoring
- Regular blood pressure assessment
- Monitor for drug toxicity:
Pitfalls and Caveats
- Avoid calcium channel blockers for wide-complex tachycardias of unknown origin 2
- Avoid combining multiple AV nodal blocking agents with longer duration of action 2
- Class IC antiarrhythmic drugs should not be used in patients with history of MI 1
- For amiodarone infusions longer than 1 hour, do not exceed concentrations of 2 mg/mL unless using a central venous catheter (risk of phlebitis) 3
- Treatment of isolated ventricular premature beats or non-sustained VT is not indicated 1